Featured Research

from universities, journals, and other organizations

Tracing The Neural Circuitry Of "Second Sight"

Date:
February 8, 2002
Source:
Howard Hughes Medical Institute
Summary:
Researchers have traced the light-sensing circuitry for a type of “second sight” that is distinct from the conventional visual system and seems to interact directly with the body’s internal clock. The researchers speculate that subtle genetic malfunctions of this machinery might underlie some sleep disorders.

Researchers have traced the light-sensing circuitry for a type of “second sight” that is distinct from the conventional visual system and seems to interact directly with the body’s internal clock. The researchers speculate that subtle genetic malfunctions of this machinery might underlie some sleep disorders.

In an article published in the February 8, 2002, Science, a research team led by Howard Hughes Medical Institute investigator King-Wai Yau described the circuitry, which consists of a subset of nerve cells that carry visual signals from the eye to the brain. The scientists showed that circadian-pacemaker nerve cells almost certainly depend on a different light-sensing pigment, called melanopsin, than the conventional visual system, which relies on rod and cone photoreceptors arrayed across the retina.

Biological, or circadian, clocks operate on a 24-hour cycle that governs sleeping and waking, rest and activity, body temperature, cardiac output, oxygen consumption and endocrine gland secretion. In mammals, the internal circadian clock resides in the brain, and sunlight is the cue that resets this clock daily.

Basic insights into the circadian system could lead to improved treatment for such problems as jet lag and depression, and even help optimize drug treatments affected by the rhythmic changes in body hormones.

"It's been known for twenty years that the eyes are required to set the circadian clock, a process called photoentrainment," said Yau, who is at The Johns Hopkins University School of Medicine. "But over the last few years or so, increasing evidence has suggested that the retinal rods and cones are not the only receptors involved in light detection." For example, studies showed that mice genetically altered to lack functioning rods and cones still showed photoentrainment of their circadian clocks, said Yau. The same non-visual, light-sensing system also appears to govern the pupillary light reflex, the process by which the pupil opens or closes in response to changes in light intensity.

Previous studies suggested that this "second sight" system consists of neural circuitry that connects the retina to the brain's circadian control center, called the suprachiasmatic nucleus (SCN), said Yau.

A key discovery, said Yau, was the identification of a candidate circadian light-sensing pigment, melanopsin, from the retina by Ignacio Provencio and his colleagues at the Uniformed Services University. Yau and his colleagues sought to map the circuitry of melanopsin-containing nerve cells from the retina to the brain. Visual signals are carried to the brain by retinal ganglion cells.

The scientists used fluorescence-labeled antibodies that selectively attached to melanopsin to label the retinal ganglion cells that might be involved in circadian photoentrainment. "We got a very clear result," said Yau. "Of the approximately 100,000 retinal ganglion cells, only about 2,500, or two percent, were labeled by the melanopsin antibody." Labeling revealed that melanopsin is present throughout those cells -- including the cell bodies, the axons and the finely branching dendrites, said Yau.

To map the connections of these cells to the brain, the scientists created a "knock-in" mouse in which each melanopsin-expressing cell also carried a marker gene called tau-lacZ, whose coded protein could be selectively stained. This protein was capable of traveling down the axons of the ganglion cells, revealing their targets.

"The labeling was just beautiful," said Yau. "It showed that the axonal projections of these cells reach out to innervate the SCN in a very dense manner.” The axons also project to other areas of the brain such as the intergeniculate leaflet, which in turn connects back to the SCN, where the main circadian pacemaker is located. Thus, there are feedback-control loops in photoentrainment that involve multiple structures of the brain. In addition, the mapping showed that the melanopsin-containing ganglion cells innervated the brain region known to control the pupillary reflex.

A major question was whether the melanopsin-expressing retinal ganglion cells are truly intrinsically sensitive to light. In an accompanying paper in the same issue of Science, David Berson and colleagues at Brown University report used pharmacological blockers to show that the retinal ganglion cells projecting to the SCN are, indeed, photosensitive by themselves. Berson, who also collaborated on Yau’s Science article, did key experiments to show that intrinsic photosensitivity and the expression of melanopsin showed strong one-to-one correlation in the retinal ganglion cells.

According to Yau, the discovery of the architecture, circuitry and photosensitivity of the melanopsin-containing retinal ganglion cells is an important step understanding how the circadian system is controlled.

Yau and his colleagues are planning more studies, such as to explore the behavioral effects of knocking out photoentrainment. They would also like to learn more about the system's neural wiring, how it detects light and how it wires itself during embryonic development. These types of studies could improve understanding of both the system itself and how it might malfunction to cause sleep disorders, said Yau.

"Sleep disorders are a major health problem that profoundly impact the lives of those affected," he said. "As we find out more about the circadian photoentrainment system, we may well discover subtle genetic alterations that cause such disorders in a previously unsuspected way."


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Tracing The Neural Circuitry Of "Second Sight"." ScienceDaily. ScienceDaily, 8 February 2002. <www.sciencedaily.com/releases/2002/02/020208075953.htm>.
Howard Hughes Medical Institute. (2002, February 8). Tracing The Neural Circuitry Of "Second Sight". ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/02/020208075953.htm
Howard Hughes Medical Institute. "Tracing The Neural Circuitry Of "Second Sight"." ScienceDaily. www.sciencedaily.com/releases/2002/02/020208075953.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins